Man made Vascular Graft Sales

Man Made Vascular Graft Sales Market Outlook

The global man-made vascular graft market has been evaluated at approximately USD 4.12 billion in 2023 and is projected to reach about USD 7.56 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of around 7.0% during the forecast period from 2025 to 2035. This growth trajectory can be attributed to a confluence of factors, including the rising incidence of cardiovascular diseases, technological advancements in graft manufacturing, and an increasing aging population that demands advanced surgical interventions. Moreover, the surge in minimally invasive surgical techniques has heightened the adoption of vascular grafts, as these procedures tend to result in lower postoperative complications and faster recovery times for patients. The expanding healthcare infrastructure across emerging economies is also playing a significant role in bolstering market growth as these regions seek to enhance their capacity to treat vascular-related ailments.

Growth Factor of the Market

The growth of the man-made vascular graft market is significantly fueled by the increasing prevalence of chronic conditions such as diabetes, obesity, and hypertension, which are key risk factors for vascular diseases. As these conditions become more common globally, the demand for effective surgical solutions, such as vascular grafts, is expected to rise. Additionally, advancements in materials science and engineering have led to the development of innovative grafts that exhibit enhanced biocompatibility and improved clinical outcomes, making them more appealing to both surgeons and patients. The evolving landscape of healthcare, with an emphasis on patient-centered care and tailored treatment plans, is also contributing to market dynamics, as healthcare providers increasingly seek grafts that can offer personalized solutions. Furthermore, the rising investment in healthcare research and development is likely to spur innovations in vascular graft technology, which will further elevate the market's growth potential.

Key Highlights of the Market

• Projected market growth at a CAGR of 7.0% from 2025 to 2035.
• Significant increase in demand due to the rise of chronic diseases globally.
• Advancements in graft design and manufacturing techniques.
• Focus on minimally invasive surgical options enhancing patient recovery.
• Growing healthcare investments in emerging economies driving market expansion.

By Product Type

Polyester Vascular Grafts:

Polyester vascular grafts are some of the most commonly used artificial grafts in vascular surgeries. Renowned for their excellent tensile strength and biocompatibility, polyester grafts are particularly favored for procedures involving large blood vessels, such as aortic replacements and peripheral bypass surgeries. The ability of these grafts to be tailored in terms of size and shape further enhances their versatility in clinical applications. Their porous nature allows for tissue ingrowth, providing improved integration within the host tissue, which minimizes the risk of graft rejection. The continued development in the modification of polyester fibers is enhancing their performance metrics, making them increasingly reliable for prolonged usage. The combination of affordability and effectiveness makes polyester grafts a popular choice among healthcare providers, thus significantly contributing to market growth.

PTFE Vascular Grafts:

Polytetrafluoroethylene (PTFE) vascular grafts are recognized for their exceptional resistance to thrombosis and their low friction properties. These characteristics make them particularly suitable for high-flow vascular regions, including hemodialysis access and arterial bypass surgeries. PTFE grafts have a smooth surface that facilitates blood flow and minimizes the risk of clot formation, which is a critical factor in vascular applications. Additionally, their durability and flexibility ensure that they can withstand the physiological stresses of the cardiovascular system without compromising structural integrity. Their ease of handling during surgical procedures and adaptability to various anatomical configurations further enhance their appeal in the clinical environment. The increasing demand for effective and durable graft materials in vascular surgeries is expected to solidify the role of PTFE grafts in the market.

Biological Vascular Grafts:

Biological vascular grafts, derived from human or animal tissues, are gaining popularity due to their natural compatibility with human biology. These grafts are particularly advantageous in pediatric surgeries and for patients with a heightened risk of immune rejection. The incorporation of living cells and tissue in biological grafts promotes natural healing and minimizes the chances of complications, making them an appealing solution for complex vascular repairs. Furthermore, advancements in preservation and processing techniques have significantly improved the longevity and usability of biological grafts. The perception of biological grafts as a more physiologically congruent option is driving their adoption, especially among healthcare providers aiming for optimal patient outcomes. As awareness of the benefits of biological options continues to rise, their market share is expected to grow significantly.

Biosynthetic Vascular Grafts:

Biosynthetic vascular grafts represent a hybrid approach that combines the benefits of both synthetic and biological materials. These grafts are engineered to mimic the natural properties of blood vessels while addressing common issues associated with traditional synthetic grafts, such as thrombosis. The unique design of biosynthetic grafts allows for improved integration with surrounding tissues, fostering a conducive environment for healing and reducing the risk of complications. Their increased flexibility and adaptability to various surgical applications are making them a preferred choice for surgeons who require versatile solutions. As innovation in biosynthetic graft technology continues, including enhanced surface characteristics and bioactive coatings, their role in the vascular graft market is anticipated to expand, providing more options for complex surgical applications.

ePTFE Vascular Grafts:

Expanded polytetrafluoroethylene (ePTFE) vascular grafts are known for their unique characteristics that offer advantages in specific surgical applications. Their microporous structure not only allows for tissue ingrowth but also provides a barrier against infection, which is crucial in surgical environments. ePTFE grafts are typically utilized in peripheral bypass surgeries and hemodialysis access due to their excellent durability and resistance to kinking. The lightweight nature of ePTFE materials contributes to ease of handling during surgical procedures, thereby improving the overall surgical experience for both the physician and patient. As the demand for grafts that promote rapid healing and integration increases, ePTFE grafts are expected to see continued growth, particularly in regions where minimally invasive techniques are being widely adopted.

By Application

Coronary Artery Bypass Surgery:

The use of vascular grafts in coronary artery bypass surgery (CABG) is a significant application that drives market demand. CABG procedures utilize grafts to reroute blood flow around blocked arteries, thus improving blood supply to the heart muscle. The effectiveness of grafts in these surgeries is critical to ensuring long-term patient outcomes. Various types of grafts, including saphenous veins and arterial grafts like the internal mammary artery, are employed, but synthetic vascular grafts are increasingly common due to their availability and performance. The growing incidence of coronary artery disease, coupled with advancements in surgical techniques, is expected to fuel further demand for vascular grafts in CABG, thereby contributing to the overall growth of the market.

Peripheral Vascular Bypass:

Peripheral vascular bypass applications account for a significant share of the man-made vascular graft market. In such procedures, grafts are used to bypass obstructed blood vessels in the limbs, thus restoring adequate blood flow. The rising prevalence of peripheral artery disease (PAD), particularly among older adults and individuals with underlying health conditions, is contributing to the increased need for these bypass surgeries. Innovative graft designs that enhance flexibility and reduce the risk of complications have led to improved outcomes for patients undergoing peripheral vascular procedures. The growing awareness of PAD and its treatments is expected to further drive the market for vascular grafts used in peripheral vascular bypass applications.

Hemodialysis Access:

Hemodialysis access is another vital application for man-made vascular grafts, as these grafts facilitate the creation of an access point for patients requiring dialysis treatment. Patients suffering from kidney failure often require reliable vascular access to ensure effective dialysis sessions. The use of vascular grafts, particularly those made from synthetic materials, allows for easier placement and improved long-term functionality compared to traditional access methods. The increasing incidence of chronic kidney diseases globally, alongside the growing aging population, is significantly driving the market for hemodialysis access grafts. As innovations continue to enhance the performance of these grafts, healthcare providers are more inclined to adopt them as standard practice for dialysis access.

Aneurysm Repair:

Aneurysm repair is a critical application for vascular grafts, particularly in the context of aortic and peripheral aneurysms. The effectiveness of grafts in providing a stable conduit for blood flow while reinforcing the weakened vessel walls is essential in preventing rupture and ensuring patient safety. The increasing prevalence of aneurysms, driven by risk factors such as hypertension and genetic predisposition, is contributing to the rising demand for grafts in these surgical interventions. The development of specialized grafts designed for aneurysm repair, which incorporate features such as endovascular delivery systems, is further enhancing their applicability and effectiveness in clinical settings. With continued advancements in surgical techniques and materials, the market for vascular grafts used in aneurysm repair is expected to see substantial growth.

Vascular Trauma Repair:

Vascular trauma repair represents a crucial application area for man-made vascular grafts, particularly in emergency medicine. Grafts are often required to restore blood flow to limbs in the event of traumatic injuries that compromise blood vessels. As trauma cases continue to rise due to factors such as road traffic accidents and industrial incidents, the demand for effective surgical interventions utilizing vascular grafts is also increasing. The ability of grafts to provide immediate and reliable solutions in critical situations underscores their importance in trauma care. Enhanced material properties that ensure graft performance in high-stress situations are contributing to their growing adoption in vascular trauma repair applications.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for man-made vascular grafts, accounting for the largest share of the market. The high volume of surgical procedures performed in hospitals, particularly cardiovascular surgeries, significantly drives the demand for vascular grafts. Hospitals typically maintain extensive inventories of various graft types to cater to diverse surgical needs, enabling them to promptly address patient requirements. Furthermore, collaborations with leading manufacturers ensure that hospitals have access to the latest advancements in graft technology, enhancing surgical outcomes. As healthcare systems continue to evolve and expand, the role of hospitals in the distribution of vascular grafts is expected to remain critical.

Specialty Clinics:

Specialty clinics are emerging as an important distribution channel for vascular grafts due to their focused approach to specific medical conditions. These clinics often specialize in areas like cardiovascular health, hemodialysis, or vascular surgery, providing tailored care that requires advanced graft solutions. The increased patient awareness regarding specialized healthcare services is driving more individuals to seek treatment at specialty clinics. Furthermore, the personalized care offered at these facilities often leads to better patient outcomes, further elevating their role in the vascular graft market. As specialty clinics expand their offerings and capabilities, their significance in the distribution of vascular grafts is anticipated to grow.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly recognized as a viable distribution channel for man-made vascular grafts. These centers offer outpatient surgical procedures, which can lead to cost-effective treatment options for patients. The rising trend of minimally invasive surgeries that can be performed in ASCs is contributing to the demand for vascular grafts, particularly for procedures such as hemodialysis access and peripheral vascular bypass. The convenience and efficiency of ASCs are appealing to both patients and healthcare providers; as a result, the use of vascular grafts in these settings is expected to increase. The growth of ASCs as a distribution channel is influencing market dynamics significantly.

Online Sales:

The advent of digital technologies has also opened up online sales as a distribution channel for vascular grafts. Although traditionally, surgical materials and grafts have been procured through direct contracts with manufacturers or distributors, the growing trend of e-commerce in healthcare is beginning to reshape this landscape. Online sales platforms offer healthcare providers convenient access to a wide array of graft products, facilitating quicker procurement processes. The increasing adoption of telemedicine and online consultations is further supporting this trend, as healthcare professionals look for efficient ways to source necessary supplies. While this channel is still in the early stages of growth, its potential to revolutionize the way vascular grafts are distributed cannot be underestimated.

By Material Type

Synthetic:

Synthetic vascular grafts dominate the market due to their durability, versatility, and consistent performance in various surgical applications. These grafts, made from materials such as polyester and PTFE, are engineered to exhibit strong mechanical properties that make them suitable for high-pressure environments, such as within the vascular system. The ability to manufacture synthetic grafts in a variety of sizes and configurations allows for customization according to individual patient needs. Moreover, technological advancements in synthetic graft development are continually enhancing their biocompatibility and reducing complications associated with their use. As a result, synthetic grafts remain a preferred choice among surgeons, driving growth in this segment of the market.

Biological:

Biological vascular grafts, encompassing those derived from human or animal tissues, are increasingly recognized for their natural compatibility with the human body. These grafts are particularly advantageous for patients who have a higher risk of complications associated with synthetic materials. The use of biological grafts can lead to improved healing processes and lower rejection rates, making them ideal for pediatric patients and others who may require vascular interventions. Despite their higher cost compared to synthetic options, the clinical benefits associated with biological grafts are driving their adoption, particularly in specialized surgical settings. As clinical data continues to support their efficacy, the segment of biological grafts is expected to expand further in the coming years.

By Region

North America holds a prominent position in the man-made vascular graft market, accounting for a substantial share of the global revenue. Factors such as advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and increased spending on medical technologies contribute to the region's dominance. The North American market is projected to grow at a CAGR of around 6.5% during the forecast period from 2025 to 2035, driven by innovations in graft technology and an increasing number of surgical procedures. The presence of leading manufacturers and a well-established reimbursement framework further bolster market growth in this region. Additionally, the emphasis on research and development in the field of vascular grafts is paving the way for new product introductions and enhancements.

Europe also plays a significant role in the global man-made vascular graft market, primarily due to the rising prevalence of vascular diseases and the growing aging population. The European market has seen a steady increase in surgical procedures, particularly in major economies such as Germany, the UK, and France. The region's stringent regulatory framework for medical devices ensures that only high-quality grafts are available, thereby enhancing patient safety and efficacy. Moreover, collaborations among healthcare providers, academic institutions, and industry players contribute to the continuous development and innovation of vascular graft products. As the healthcare landscape in Europe continues to evolve, the market for vascular grafts is expected to maintain a steady growth trajectory.

Opportunities

The man-made vascular graft market is ripe with opportunities, particularly as technological advancements continue to shape the landscape of vascular surgery. Innovations in material science, such as the development of bioengineered grafts that better mimic the properties of natural blood vessels, are paving the way for improved patient outcomes. As healthcare providers increasingly embrace minimally invasive surgical techniques, the demand for grafts that facilitate these procedures is expected to rise significantly. Moreover, emerging economies are investing heavily in healthcare infrastructure, creating a favorable environment for the growth of the vascular graft market. Expanding the reach of vascular graft products into these untapped markets can provide substantial revenue opportunities for manufacturers. The focus on patient-centric care and personalized medicine also opens avenues for tailored graft solutions, further enhancing the market's potential.

Another significant opportunity lies in the growing emphasis on preventive healthcare and early intervention strategies. As awareness of cardiovascular diseases and their risk factors continues to rise, there is a greater push toward early diagnosis and treatment. This trend is leading to more surgical interventions that require vascular grafts, thus driving market demand. Additionally, collaborations between hospitals, specialty clinics, and manufacturers can foster innovation and drive the development of next-generation graft materials. Investments in research and development aimed at improving the performance and longevity of vascular grafts will also enhance their appeal among healthcare providers. As the market evolves, establishing strategic partnerships and focusing on research initiatives can position companies favorably to capitalize on these emerging opportunities.

Threats

Despite the promising outlook for the man-made vascular graft market, several threats could impede growth and market stability. One of the primary concerns is the ongoing risk of complications associated with vascular grafts, such as infection, graft failure, and thrombosis. These complications can result in adverse patient outcomes, leading to increased scrutiny from regulatory bodies and impacting adoption rates among healthcare providers. Additionally, the market is witnessing increased competition from alternative treatment modalities, such as endovascular techniques, which may reduce the demand for traditional vascular grafts. Furthermore, the growing trend of personalized medicine and tailored treatment approaches may challenge the standardization of graft products, forcing manufacturers to adapt rapidly to changing consumer demands. Keeping pace with these challenges while ensuring product efficacy and safety is essential for sustained market growth.

Another critical restrainer impacting the market is the high cost associated with advanced vascular graft technologies. While biological and innovative synthetic grafts may offer superior performance, their elevated price points can limit accessibility for healthcare providers, especially in developing regions with constrained budgets. This financial barrier can hinder widespread adoption and create disparities in treatment options available to patients. Moreover, reimbursement policies play a vital role in influencing the market landscape, and unfavorable reimbursement conditions could deter healthcare facilities from procuring advanced graft solutions. As such, addressing pricing strategies and advocating for more favorable reimbursement frameworks will be crucial for unlocking the full potential of the man-made vascular graft market.

Competitor Outlook

• Medtronic
• Baxter International Inc.
• Gore Medical
• Terumo Corporation
• Boston Scientific Corporation
• Cook Medical
• Cardinal Health
• JOTEC GmbH
• Sorin Group
• Abbott Laboratories
• MicroPort Scientific Corp.
• Ethicon (Johnson & Johnson)
• Asahi Intecc Co., Ltd.
• Getinge AB
• Vascutek Ltd.

The competitive landscape of the man-made vascular graft market is characterized by a mix of established players and emerging companies, all vying for market share in this rapidly evolving sector. Major manufacturers such as Medtronic and Baxter International Inc. lead the market with their extensive product portfolios and strong brand recognition. These companies have made significant investments in research and development, enabling them to introduce innovative graft solutions that cater to the evolving needs of healthcare providers. Additionally, strategic collaborations and partnerships are commonplace, aiming to enhance product offerings and expand market reach. The competitive dynamics are further influenced by regional players who are capitalizing on localized demand and addressing specific healthcare challenges within their markets.

Medtronic, a global leader in medical technologies, plays a pivotal role in the vascular graft market with its comprehensive range of innovative graft solutions. The company is known for its commitment to research and development, which has led to numerous breakthroughs in graft technology. Medtronic's extensive distribution network and strong relationships with healthcare providers position it favorably within the market. The company's focus on minimally invasive procedures and patient-centric solutions allows it to stay ahead of the competition while catering to the growing demand for advanced vascular grafts. With a robust pipeline of new products and ongoing investment in innovation, Medtronic is well-positioned to maintain its leadership position in the market.

Baxter International Inc. is another significant player in the man-made vascular graft market, known for its commitment to improving patient outcomes through innovative medical solutions. The company offers a variety of vascular graft products that cater to different surgical needs, including those for hemodialysis access and peripheral vascular procedures. Baxter's focus on enhancing product effectiveness and safety through advanced manufacturing techniques has garnered it a loyal customer base among healthcare providers. Additionally, the company's strong emphasis on clinical research and collaboration with key opinion leaders ensures that it remains at the forefront of market trends and advancements. As the demand for vascular grafts continues to grow, Baxter's strategic initiatives are expected to bolster its competitive stance in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Getinge AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 JOTEC GmbH
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sorin Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cook Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Gore Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Vascutek Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cardinal Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Asahi Intecc Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Baxter International Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 MicroPort Scientific Corp.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Ethicon (Johnson & Johnson)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Man made Vascular Graft Sales Market, By Application
    • 6.1.1 Coronary Artery Bypass Surgery
    • 6.1.2 Peripheral Vascular Bypass
    • 6.1.3 Hemodialysis Access
    • 6.1.4 Aneurysm Repair
    • 6.1.5 Vascular Trauma Repair
  • 6.2 Man made Vascular Graft Sales Market, By Product Type
    • 6.2.1 Polyester Vascular Grafts
    • 6.2.2 PTFE Vascular Grafts
    • 6.2.3 Biological Vascular Grafts
    • 6.2.4 Biosynthetic Vascular Grafts
    • 6.2.5 ePTFE Vascular Grafts
  • 6.3 Man made Vascular Graft Sales Market, By Material Type
    • 6.3.1 Synthetic
    • 6.3.2 Biological
  • 6.4 Man made Vascular Graft Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Man made Vascular Graft Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Man made Vascular Graft Sales market is categorized based on

By Product Type

• Polyester Vascular Grafts
• PTFE Vascular Grafts
• Biological Vascular Grafts
• Biosynthetic Vascular Grafts
• ePTFE Vascular Grafts

By Application

• Coronary Artery Bypass Surgery
• Peripheral Vascular Bypass
• Hemodialysis Access
• Aneurysm Repair
• Vascular Trauma Repair

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Sales

By Material Type

• Synthetic
• Biological

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Baxter International Inc.
• Gore Medical
• Terumo Corporation
• Boston Scientific Corporation
• Cook Medical
• Cardinal Health
• JOTEC GmbH
• Sorin Group
• Abbott Laboratories
• MicroPort Scientific Corp.
• Ethicon (Johnson & Johnson)
• Asahi Intecc Co., Ltd.
• Getinge AB
• Vascutek Ltd.